146 related articles for article (PubMed ID: 17453334)
1. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
[TBL] [Abstract][Full Text] [Related]
2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
4. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
[TBL] [Abstract][Full Text] [Related]
5. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH
Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348
[TBL] [Abstract][Full Text] [Related]
6. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo.
Van Themsche C; Parent S; Leblanc V; Descôteaux C; Simard AM; Bérubé G; Asselin E
Endocr Relat Cancer; 2009 Dec; 16(4):1185-95. PubMed ID: 19661132
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
8. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
Liu J; Sidell N
Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415
[TBL] [Abstract][Full Text] [Related]
9. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
10. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
[TBL] [Abstract][Full Text] [Related]
12. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
[TBL] [Abstract][Full Text] [Related]
13. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.
Yao Y; Zhou Q
Breast Cancer Res Treat; 2010 May; 121(1):233-40. PubMed ID: 19760501
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
[TBL] [Abstract][Full Text] [Related]
16. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.
Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH
Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309
[TBL] [Abstract][Full Text] [Related]
17. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
[TBL] [Abstract][Full Text] [Related]
18. Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro.
Charles AK; Darbre PD
J Appl Toxicol; 2009 Jul; 29(5):422-34. PubMed ID: 19338011
[TBL] [Abstract][Full Text] [Related]
19. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
20. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]